Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01631721 · ClinicalTrials.gov registry record

Couple & Family Contexts

A clinical trial, sponsored by New York University.

Completed
Registry status
2,960
Enrollment target

NCT01631721: Completed study, sponsored by New York University.

NCT01631721 is a clinical trial that has completed, run by New York University. The registered enrollment target is 2,960 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01631721 has completed, sponsored by New York University.

COMPLETED
Registry status
2,960 participants
Enrollment target

Study Summary

The purpose of this study is to understand the factors that lead to adolescent sexual risk behavior by investigating both the family contexts and romantic relationships that influence adolescent couples' decision-making.

Primary Outcome

Number of times ever had vaginal intercourse with current romantic partner

Trial Details

FieldValue
Enrollment Target 2,960 participants
Start Date 2010-11
Est. Completion 2016-02
New York University

83 total trials

What the finished NCT01631721 record still lists

NCT01631721 is an observational study that tracks outcomes without assigning an intervention. Its 2,960 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01631721 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01631721 about?

NCT01631721 is a clinical study titled "Couple & Family Contexts". The purpose of this study is to understand the factors that lead to adolescent sexual risk behavior by investigating both the family contexts and romantic relationships that influence adolescent couples' decision-making.

What is the current status of trial NCT01631721?

This trial is currently completed. The enrollment target is 2,960 participants. The study started on 2010-11. Estimated completion is 2016-02.

Who is sponsoring clinical trial NCT01631721?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03331380 · 2,950 participants · NA

    Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System

  • NCT05849961 · 2,946 participants

    Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)

  • NCT05297734 · 2,996 participants · NA

    Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • NCT03860883 · 2,998 participants · NA

    Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01631721, the US trial registry maintained by the National Library of Medicine. NCT01631721 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.